Phio shareholders approve incentive plan amendment, adding 125,500 shares

Phio Pharmaceuticals Corp.

At July 20, 2023 annual meeting, shareholders approved amendment to 2020 Long Term Incentive Plan.
Plan shares increased by 125,500 to a total of 225,500 shares available for issuance.
All five director nominees elected: Bitterman, Bradford, Ferrara, Freeman, Lockshin.
BDO USA LLP ratified as independent auditor for FY 2023 with 605,026 for, 21,903 against.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Phio Pharmaceuticals Corp. shareholders approved Ratification of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 at the 2023-07-20 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-07-20

Exact text from the filing

Proposal 2: Ratification of Auditors For Against Abstain 605,026 21,903 3,171

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Phio Pharmaceuticals Corp. shareholders approved Election of five directors to serve until the 2024 Annual Meeting at the 2023-07-20 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-07-20

Exact text from the filing

Nominee For Withheld Broker Non-Votes Robert J. Bitterman 126,094 17,995 486,011

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Phio Pharmaceuticals Corp. shareholders approved Amendment and restatement of the 2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan to increase the number of shares by 125,500 at the 2023-07-20 meeting.

Proposal: equity plan
Outcome: passed
Meeting: 2023-07-20

Exact text from the filing

Proposal 3: Amendment and Restatement of the 2020 Phio Pharmaceuticals Corp. Long Term Incentive Plan For Against Abstain Broker Non-Votes 98,254 44,696 1,139 486,011

View on SEC.gov

560 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Phio Pharmaceuticals Corp. filing history →

Source: SEC EDGAR

accession 0001683168-23-005094

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.